AccuraGen Holdings Limited
About UsSince its inception in 2013, AccuraGen has pioneered the development of liquid biopsy technology to facilitate more personalized cancer treatment. Our international team of scientists brings together the best of industry with the best of academia. We currently operate from two locations: Menlo Park, California and Shanghai, China.
Richard Myers, PhD
The former director of the Stanford Human Genome Center, Dr. Myers currently serves as the president of the HudsonAlpha Institute for Biotechnology.
David Euhus, MD
Dr. David Euhus is the chief of breast surgery in the Department of Surgical Oncology at Johns Hopkins University.
+ Managing Director of Decheng Capital
+ Executive Partner of Denlux Capital
+ Head of Roche Sequencing and Tissue Diagnostics
+ General Manager of Junson Capital